Loading provider…
Loading provider…
Infectious Disease Physician in New York, NY
NPI: 1255421426Primary Practice Location
NEW YORK-PRESBYTERIAN HOSPITAL
5141 Broadway, New York, NY
Primary Employer
Weill Medical College of Cornell
med.cornell.edu
HQ Phone
Get MD Kristen's Phone NumberMobile
Get MD Kristen's MobileLooking to connect with more Physicians?
Dmand AI gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Get Started for Freearrow_outwardNY State Medical License
NY State Medical License
2001 - 2027

American Board of Internal Medicine
Infectious Disease
Vagelos College of Physicians and Surgeons
vagelos.columbia.edu
Medical School
Until 1999
New York Presbyterian Hospital (Cornell Campus)
Fellowship • Infectious Disease
2002 - 2005
Residency • Internal Medicine
1999 - 2002
| # | Procedure Code (CPT®/HCPCS II) | Procedure Patients | Procedure Volume |
|---|---|---|---|
| 1 | 99232Subsequent hospital inpatient care, typically 25 minutes per day | 36 | 92 |
| 2 | 99222Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | 28 | 28 |
Authors: Asa Radix, Bisher Akil, Shirish Huprikar, Andrew Talal, Daniel Fierer
Journal: PLoS One
Publication Date: 2020-07-15
Authors: Ronald Nahass, Raymond Chung, Ravi Jhaveri, Maureen Jonas, Timothy Morgan, Marion Peters, Norah Terrault, Debika Bhattacharya
Journal: Clin Infect Dis
Lead Sponsor: National Institute of Allergy and Infectious Diseases (NIAID)
Collaborators: Dynavax Technologies Corporation
Intervention / Treatment: BIOLOGICAL: HEPLISAV-B, BIOLOGICAL: ENGERIX-B
Lead Sponsor: Weill Medical College of Cornell University
Collaborators: Gilead Sciences
Intervention / Treatment: OTHER: Rapid Treatment strategy, OTHER: Usual Care (facilitated referral)
Lead Sponsor: Advancing Clinical Therapeutics Globally for HIV/AIDS and Other Infections
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Intervention / Treatment: DRUG: ribavirin, DRUG: pioglitazone, DRUG: peginterferon